H2 Medical Technologies

H2 Medical Technologies is a Czech MedTech company and a subsidiary of H2 Global Group, focused on the research, development, and manufacturing of molecular hydrogen-based therapeutic solutions. The company specializes in patented medical devices for hydrogen inhalation and hydration, primarily targeting neurodegenerative diseases like Alzheimer's and mild cognitive impairment. Their technology is based on over three decades of scientific research by co-founder Professor Shigeo Ohta, a pioneer in molecular hydrogen medicine. H2 Medical Technologies is currently conducting Europe's first fully approved clinical trial for hydrogen inhalation as a neuroprotective therapy and offers a range of products for wellness, sports recovery, and dental care. The company is expanding its global footprint, with ongoing regulatory processes for EU registration and future FDA approval.